BD TO ANNOUNCE FINANCIAL RESULTS FOR ITS SECOND QUARTER OF FISCAL 2022
BD (Becton, Dickinson and Company) will report its financial results for the second quarter of fiscal year 2022 on May 5, 2022, at approximately 6:30 a.m. ET. The announcement will include summary financial information for the quarter ending March 31, 2022. Management will conduct a conference call at 8 a.m. ET on the same day to discuss results and operational strategy.
Investors can access the news release and presentation materials on the company’s investor relations website.
- None.
- None.
FRANKLIN LAKES, N.J., April 7, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will report financial results for its second quarter of fiscal year 2022 on Thursday, May 5, 2022. A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors, along with related presentation materials. The news release and presentation materials will include summary financial information for the company's second quarter of fiscal year 2022, which ended on Thursday, March 31, 2022.
BD management will host an audio webcast at 8 a.m. ET on May 5, 2022 to discuss its financial results and provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics, and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
Any forward-looking statements are subject to risks and uncertainties such as those described in BD's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Contacts: | |
Media | Investors |
Troy Kirkpatrick | Francesca DeMartino |
VP, Public Relations | SVP, Investor Relations |
858.617.2361 | 201.847.5743 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-to-announce-financial-results-for-its-second-quarter-of-fiscal-2022-301520333.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
When will BD announce its financial results for Q2 2022?
What time will BD's Q2 2022 financial results be released?
When is the audio webcast for BD's Q2 2022 financial results?
Where can I find BD's financial results and presentation materials?
